Engagement and Voting Outlook: Adapting to a 2026 Landscape
Adjust the tack, but hold the course
Market, regulatory, and geopolitical trends are influencing the way investors are engaging with investee companies. In 2025, shareholders sponsored fewer resolutions, while large institutions withdrew from some large collaborative initiatives, causing them to be restructured or cancelled.
Direct dialogues and smaller coalitions are likely to grow in importance.
We believe these can support more targeted, out-come oriented engagements. While we have not reduced our participation in large, high-profile collaborative initiatives, it may be harder for these to be as effective as they had been in prior years.
Governance remains the prerequisite.
Our philosophy is that governance is the framework for translating corporate objectives into long-term sustainable financial results. Oversight and accountability must be in place first.
And the next goals? Climate mitigation -- maintaining active dialogue in an uncertain world; increasing recognition of biodiversity, natural capital, and human capital as financial and investment risks. Human capital, for example, gained importance as a risk during the Covid period – and we have engaged with rapidly-growing firms on the growth risks and opportunities of managing their human capital. We also take the financial and other risks of doing business in Conflict-Affected Areas seriously. Supply chains, AI, workforce availability – investors need transparency.
Want more on our outlook for 2026?
For the first time, our Annual Engagement and Voting Report includes an outlook for the coming year as a part of our structured engagement approach. By setting out the sub-trends and themes linked to the broader priorities defined in our engagement policy, and where we expect to focus our stewardship, we aim to give our clients greater transparency on how dialogue and voting support our investment decisions.
Want the complete experience?
Latest analyses
-
Why the environmental transition is fuelling the next boom in energy, industry and resources -
European Tech autonomy: a clearer path
The structural shift towards European autonomy is already underway in the technology sector. Having relied on American and Asian capabilities for too long, Europe is now committed to reducing its technological dependence by strengthening its domestic capacities in strategic areas. -
A transition gaining speed
The environmental transition has entered a new phase. What was once seen as a gradual, policy-led shift is unfolding as a faster, economically driven transformation. Technology, cost dynamics and rising physical risks are converging, turning environmental change into a central force redefining growth, capital allocation and corporate strategy. -
Generating Impact in the Bond Space – But How?
Impact investments have kept rising over the past decades, reaching $1.6 trillion USD according to the Global Impact Investing Network (GIIN) – that is $ 1.6 trillion USD in assets allocated toward solutions supporting the Sustainable Development Goals. -
Engagement and Voting Outlook
Market, regulatory, and geopolitical trends are influencing the way investors are engaging with investee companies. In 2025, shareholders sponsored fewer resolutions, while large institutions withdrew from some large collaborative initiatives, causing them to be restructured or cancelled. -
Brand Values: Unravelling Luxury Goods Risks
If brand value is image, reputation, and a track record of quality, the higher the price of the product, the more important that image is for pricing and profit. And the more susceptible to negative news which might affect that image. -
Engaging with Luxury Brand Companies: A Conversation with Benjamin Chekroun
Why are we engaging with companies on their supply chains? Their supply chains have unique and high-risk elements. These come into focus was we look at our larger engagement campaign on supply chains generally. -
World Cancer Day : Innovation, Hope, and the Future of Oncology
Precision oncology is entering a new era—one defined by earlier detection, personalised treatment, and the growing potential for long-term remission or cure.